Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Streaming Stock Quotes Are
Bristol-Myers Squibb Co
(BMY :
)
Real Time Stock Quote | Source:
Extended Hours
---
Last Trade
---
*
After Hours Change
---
Volume
---
After Hours
---
Last Trade
---
*
Change
---
Volume
---
Trade Time
BMY FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
Final Glance: Pharmaceuticals companies
3 hrs ago - The Associated Press
Midday Glance: Pharmaceuticals companies
7 hrs ago - The Associated Press
INTERVIEW-AstraZeneca turnaround is 3-4 year journey, says CEO
8 hrs ago - Reuters
Early Glance: Pharmaceuticals companies
10 hrs ago - The Associated Press
Final Glance: Pharmaceuticals companies
17 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
17 Jun 2013 - The Associated Press
Cramer: A 'Nightmare Scenario' for Bulls and Bears
17 Jun 2013 - CNBC.com
Early Glance: Pharmaceuticals companies
17 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
14 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
14 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
14 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
13 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
13 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
13 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
12 Jun 2013 - The Associated Press
Cramer: How to Ride Out the Weakness
12 Jun 2013 - CNBC.com
Midday Glance: Pharmaceuticals companies
12 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
12 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
11 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
11 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
11 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
10 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
10 Jun 2013 - The Associated Press
Final Glance: Pharmaceuticals companies
07 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
07 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
07 Jun 2013 - The Associated Press
Sanofi steps up diabetes drive as rivals raise the stakes
07 Jun 2013 - Reuters
Final Glance: Pharmaceuticals companies
06 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
06 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
06 Jun 2013 - The Associated Press
ANALYSIS-After tech success, Israel seeks life sciences growth
06 Jun 2013 - Reuters
Final Glance: Pharmaceuticals companies
05 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
05 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
05 Jun 2013 - The Associated Press
ANALYSIS-New cancer breakthroughs add pressure to control costs
05 Jun 2013 - Reuters
Bristol-Myers, AstraZeneca get faster FDA review
04 Jun 2013 - The Associated Press
Midday Glance: Pharmaceuticals companies
04 Jun 2013 - The Associated Press
Early Glance: Pharmaceuticals companies
04 Jun 2013 - The Associated Press
Cramer: Out with the New, In with the Old
03 Jun 2013 - CNBC.com
Just Another Manic Monday?
03 Jun 2013
Big Pharma On the Move
03 Jun 2013
Best Buy Gets a Boost
03 Jun 2013
Bristol and Merck Shares Surge on Cancer Drug News
03 Jun 2013 - CNBC.com
Midday Movers: PCAR, YELP, P & More
03 Jun 2013 - CNBC.com
Rise In Melanoma Treatments
03 Jun 2013
Battling Cancer: ASCO Movers
03 Jun 2013
Monday's Market Roadmap
03 Jun 2013
Pharma's Cancer Fight Makes Strides
03 Jun 2013
Early Movers: MRK, GSK, AAPL, MSFT, BMY & More
03 Jun 2013 - CNBC.com
ASCO: 'Building Bridges to Conquer Cancer'
03 Jun 2013
UPDATE 1-Merck melanoma drug shrinks tumors in 38 percent of patients
02 Jun 2013 - Reuters
Merck melanoma drug shrinks tumors in 38 percent of patients
02 Jun 2013 - Reuters
Amgen melanoma drug improved survival by 21 pct in interim look
01 Jun 2013 - Reuters
Stocks to Shrug Off Blood-Pressure Drug Dispute
31 May 2013 - CNBC.com
3 to Watch: GM, BMY & L
31 May 2013
Leading the Fight Against Cancer
31 May 2013
Searching For a Cancer Breakthrough
31 May 2013
Best Plays in Big Pharma
31 May 2013
Cramer: Here Are Two Stocks I Sold
31 May 2013 - CNBC.com
Stocks to Watch at This Year's Biotech Super Bowl
31 May 2013 - CNBC.com
Krispy Kreme & Lionsgate Beat the Street
30 May 2013
UK cost agency backs Astra, Bristol diabetes drug in some cases
29 May 2013 - Reuters
Gold on Track for Best Weekly Gain
24 May 2013
European Market Opens Sharply Lower
23 May 2013
US STOCKS-Wall St falters in volatile session on Fed worries
22 May 2013 - Reuters
Stocks Tumble Nearly 1% on Fed Tapering Fears
22 May 2013 - CNBC.com
US STOCKS-Wall St little changed as investors weigh Bernanke comments
22 May 2013 - Reuters
US STOCKS-Wall Street rises as concern eases over Fed tapering
22 May 2013 - Reuters
Cramer's Six in 60: SodaStream
22 May 2013
Immune system cancer drugs tipped to be a $35 bln market
22 May 2013 - Reuters
Cramer's Watch List Ahead of Big Cancer Conference
20 May 2013 - CNBC.com
The War Against Cancer
20 May 2013
Monday's Market Roadmap
20 May 2013
Markets
Economy
Companies
Top News & ANALYSIS
Fed May Not Be Able to Tame Volatile Trading
Google Facilitates Illegal Activity, Say State AGs
Yellen to Succeed Bernanke?
Fast Money Traders: 'Full-Speed Ahead' Before Fed
Adobe Outlook 'Pretty Impressive': Analyst
United Elite Status? Depends on How Much You Spend
Icahn Proposes Tender for 1.1 Billion Dell Shares
NYSE Bomb Plot Foiled by Surveillance Program: FBI
Home Builders Slow New Construction, Raise Prices
Forgot to 'Google' Your Financial Advisor?
SPECIAL OFFER
Download Free Annual Report.